Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects

ClinicalTrials.gov ID: NCT02536833

Public ClinicalTrials.gov record NCT02536833. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy, safety, and tolerability of three different strengths of SM04690 injected in the target knee joint of moderately to severely symptomatic osteoarthritis (OA) subjects.

Study identification

NCT ID
NCT02536833
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biosplice Therapeutics, Inc.
Industry
Enrollment
455 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2015 (Actual)
Primary completion
Apr 20, 2017 (Actual)
Completion
Apr 20, 2017 (Actual)
Last update posted
Mar 17, 2021

2015 – 2017

United States locations

U.S. sites
36
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Research Site Mobile Alabama 36608 —
Research Site Phoenix Arizona 85029 —
Research Site Tucson Arizona 85712 —
Research Site El Cajon California 92020 —
Research Site Rancho Mirage California 92270 —
Research Site Spring Valley California 91978 —
Research Site Denver Colorado 80230 —
Research Site Clearwater Florida 33761 —
Research Site Coral Gables Florida 33134 —
Research Site Jacksonville Florida 32216 —
Research Site Miami Florida 33173 —
Research Site West Palm Beach Florida 33409 —
Research Site Woodstock Georgia 30189 —
Research Site Newton Kansas 67114 —
Research Site Wichita Kansas 67205 —
Research Site Lexington Kentucky 40504 —
Research Site Frederick Maryland 21702 —
Research Site Boston Massachusetts 02111 —
Research Site Worcester Massachusetts 01605 —
Research Site 1 St Louis Missouri 63141 —
Research Site 2 St Louis Missouri 63141 —
Research Site Orchard Park New York 14127 —
Research Site Rochester New York 14609 —
Research Site Raleigh North Carolina 27612 —
Research Site Salisbury North Carolina 28144 —
Research Site Cincinnati Ohio 45246 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Rapid City South Dakota 57702 —
Research Site Knoxville Tennessee 37912 —
Research Site Austin Texas 78745 —
Research Site Houston Texas 77074 —
Research Site West Layton Utah 84041 —
Research Site Charlottesville Virginia 22911 —
Research Site Richmond Virginia 23225 —
Research Site Franklin Wisconsin 53132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02536833, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02536833 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →